Effect of device and formulation on delivery of budesonide suspensions by nebulizers

M. Keller, J. Jauernig, F. C. Lintz, M. Knoch (Munich, Germany)

Source: Annual Congress 2002 - Bronchial responsiveness, nebulization, devices and airway inflammation
Session: Bronchial responsiveness, nebulization, devices and airway inflammation
Session type: Thematic Poster Session
Number: 3359
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Keller, J. Jauernig, F. C. Lintz, M. Knoch (Munich, Germany). Effect of device and formulation on delivery of budesonide suspensions by nebulizers. Eur Respir J 2002; 20: Suppl. 38, 3359

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Comparison of aerosol delivery from two inhaler technique-guidance devices.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Estimation of efficiency of new combined preparation built-in-liposomes budesonide compared with water budesonide suspension
Source: Eur Respir J 2004; 24: Suppl. 48, 83s
Year: 2004

A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Comparison of systemic pharmacodynamic effects of two HFA formulations of formoterol fumarate delivered by pressurised metered dose inhaler in healthy subjects
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Improvement in the drug delivery of salmeterol/fluticasone via a novel breath actuatedpressurized metered dose inhaler with a dose counter
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009

Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM)
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009

Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019

Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020